Factor V Leiden and prothrombin gene mutations in Egyptian cases with unexplained recurrent pregnancy loss

Hematology

Volumn 16, Issue 1, 2011, Pages 59-63

  Settin, Ahmad ^a,d   Alkasem, RababAbo ^a   Ali, Ehab ^b   ElBaz, Rizk ^a   Mashaley, Abdel Megid ^c  

^a MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

^b Tanta University   (Egypt)

^c MANSOURA UNIVERSITY   (Egypt)

^d QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

Factor V Leiden; Prothrombin; Recurrent pregnancy loss; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; CONTROLLED STUDY; EGYPT; FEMALE; FEMALE INFERTILITY; FETUS WASTAGE; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT ABORTION; RISK FACTOR; THROMBOPHILIA;

ABORTION, HABITUAL; ADULT; CASE-CONTROL STUDIES; EGYPT; FACTOR V; FEMALE; HUMANS; MUTATION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROTHROMBIN; RISK FACTORS; THROMBOPHILIA; YOUNG ADULT;

EID: 79551695127     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453311X12902908411959     Document Type: Article

References (32)

1. Press RD, Bauer KA, Kujovich JL, Heit JA. Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med 2002;126:1304-18.
2. Belinda C, Gavin S, Lesley R. Recurrent miscarriage: pathophysiology and outcome. Obstet Gynacol 2005;17:591-7.
3. Kovalevsky G, Gracia CR, Jesse A, Berlin JA, Sammel MD, Barnhart KT. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss. A meta-analysis. Arch Intern Med 2004;164:558-63.
4. Rosendorff A, Dorfman DM. Activated protein c resistance and factor V Leiden: a review. Arch Pathol Lab Med 2007;131:866-71.
5. Dahlback B. Procoagulant and anticoagulant properties of coagulation factor V. Factor V Leiden (APC resistance) causes hypercoagulability by dual mechanisms. J Lab Clin Med 1999;133:415-22.
6. Nicolaes GA, Dahlback B. Factor V and thrombotic disease: description of a janus-faced protein. Arterioscler Thromb Vasc Biol 2002;22:530-8.
7. Dahlback B. Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases. J Intern Med 2005;257:209-23.
8. Raziel A, Kornberg Y, Friedler S, Schachter M, Sela BA, Ron-El R. Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss. Am J Reprod Immunol 2001;45:65-71.
9. Rai R, Tuddenham E, BackosM, Jivraj S, El'Gaddal S, Choy S, et al. Thromboelastography, whole blood haemostasis and recurrent miscarriage. Hum Reprod 2003;18:2540-3. (Pubitemid 37536618)
10. Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000;342:374-80.
11. Kujovich JL. Thrombophilia and pregnancy complications. Am J Obstet Gynecol 2004;191:412-24.
12. Serour G, Younis N, Hefnawi F, Daghistani H, El-bahy M, Nawara M, et al. Pregnancy wastage. Popul Sci 1981;(2):57-69.
13. Ripoll L, Paulin D, Thomas S, Drouet LO. Multiplex PCR-mediated site-directed mutagenesis for one-step determination of factor V Leiden and G20210A transition of the prothrombin gene. Thromb Haemost 1997;78:960-1.
14. Hezard N, Cornillet L, Lefebvre P, Gillot L, Potron G, Nguyen P. Multiplex ASA PCR for a simultaneous determination of factor V Leiden gene G-A20210 Prothrombin gene and C-T677 MTHFR gene mutations. Thromb Haemost 1998;79:1054-5.
15. Krause M, Zwinge B, Vigh TH, Scharrer I. Important role of FV G1691A in women with pregnancy loss without apparent causes. J Thromb Haemost 2003;1:12-8.
16. Pabinger I, Vormittag R. Thrombophilia and pregnancy outcomes. J Thromb Haemost 2005;3:1603-10.
17. Ulu A, Elsobky E, Elsayed M, Yidiz Z, Tekin M, Akar N. Frequency of five thrombophilic polymorphisms in the Egyptian population. Turk J Hematol 2006;23:100-3.
18. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Thrombophilic polymorphisms in women with fetal loss. Thromb Haemost 1999;82:6-9.
19. Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T, et al. Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C6777T, are associated with recurrent miscarriages. Hum Reprod 2000;15:458-62.
20. Zammiti W, Mtiraoui N, Mercier E, Abboud N, Saidi S, Mahjoub T, et al. Association of factor V gene polymorphisms (Leiden; Cambridge; Hong Kong and HR2 haplotype) with recurrent idiopathic pregnancy loss in Tunisia. A case-control study. Thromb Haemost 2006;95:612-7.
21. Mtiraoui N, Borgi L, Hizem S, Nsiri B, Finan RR, Gris JC, et al. Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol 2005;119:164-70.
22. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G, et al. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997;77:822-4.
23. Sehirali S, Inal MM, Yildirim Y, Balim Z, Kosova B, Karamizrak T, et al. Prothrombin G20210A mutation in cases with recurrent miscarriage: a study of the Mediterranean population. Arch Gynecol Obstet 2005;273:170-3.
24. Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod 2002;17:1633-37.
25. Sottilotta G, Oriana V, Latella C, Luise F, Piromalli A, Ramirez F, et al. Genetic prothrombotic risk factors in women with unexplained pregnancy loss. Thromb Res 2006;117:681-4.
26. Sotiriadis A, Vartholomatos G, Pavlou M, Kolaitis N, Dova L, Stefos T, et al. Combined thrombophilic mutations in women with unexplained recurrent miscarriage. Am J Reprod Immunol 2007;57:133-41.
27. Mougiou A, Androutsopoulos G, Karakantza M, Theodori E, Decavalas G, Zoumbos N. Inherited thrombophilia screening in Greek women with recurrent fetal loss. Clin Exp Obstet Gynecol 2008;35:172-4.
28. Altintas A, Pasa S, Akdeniz N, Cil T, Yurt M, Ayyildiz O, et al. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Ann Hematol 2007;86:727-31.
29. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361:901-8.
30. Kovacheva K, Ivanov P, Konova E, Simeonova M, Komsa-Penkova R. Genetic thrombophilic defects (factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss. Akush Ginekol (Sofiia) 2007;46:10-6.
31. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000;343:1015-8.
32. Pihusch R, Buchholz T, Lohse P, Rübsamen H, Rogenhofer N, Hasbargen U, et al. Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. Am J Reprod Immunol 2001;46:124-31.